Orange Fruit Roadshow: Ophthalmology Special Session Invites Participants

Innovation is the core driving force behind industrial development. In recent years, the state has actively strategized and strongly supported the translation of scientific research achievements into practical applications, introducing numerous supportive policies and incorporating such translation efforts into the “performance evaluation” metrics for hospitals and universities, thereby incentivizing scientists to step out of clinical settings and laboratories from the very source. However, the journey from an early-stage scientific concept to laboratory outcomes, and further to industrialization and commercialization, is exceedingly challenging, requiring concerted resources and support from multiple stakeholders across the industry.

Based on this, the “Orange Fruit Roadshow” is hereby launched. As part of the “Orange Growth Plan,” a brand dedicated to translating scientific research achievements into medical innovations, the Orange Fruit Roadshow is initiated by VCBeat, VB100, VCBeat Orange Fruit Bureau, and Eggshell Capital. In collaboration with 13 leading institutions—including Sequoia China, Legend Capital, Honghui Capital, Matrix Partners China, Qiming Venture Partners, Bohe Angels, Sinovation Ventures, Zhongke Star, AstraZeneca, BD Medical, Boston Scientific, Ascletis Pharma, and Omega Consulting—the event establishes a platform for communication and cooperation between high-quality scientific innovation projects and top-tier capital firms and enterprises. This initiative aims to accelerate the translation of research outcomes and support project growth.

“Orange Fruit Roadshow” Episode 1: Ophthalmology Special Session will be held online on September 23.

VCBeat: Mr. Huang

Tel: 17300219744